Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. / Rask-Madsen, Christian; Domínguez, Helena; Ihlemann, Nikolaj; Hermann, Thomas; Køber, Lars; Torp-Pedersen, Christian.

I: Circulation, Bind 108, Nr. 15, 2003, s. 1815-21.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Rask-Madsen, C, Domínguez, H, Ihlemann, N, Hermann, T, Køber, L & Torp-Pedersen, C 2003, 'Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans', Circulation, bind 108, nr. 15, s. 1815-21. https://doi.org/10.1161/01.CIR.0000091406.72832.11

APA

Rask-Madsen, C., Domínguez, H., Ihlemann, N., Hermann, T., Køber, L., & Torp-Pedersen, C. (2003). Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation, 108(15), 1815-21. https://doi.org/10.1161/01.CIR.0000091406.72832.11

Vancouver

Rask-Madsen C, Domínguez H, Ihlemann N, Hermann T, Køber L, Torp-Pedersen C. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation. 2003;108(15):1815-21. https://doi.org/10.1161/01.CIR.0000091406.72832.11

Author

Rask-Madsen, Christian ; Domínguez, Helena ; Ihlemann, Nikolaj ; Hermann, Thomas ; Køber, Lars ; Torp-Pedersen, Christian. / Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. I: Circulation. 2003 ; Bind 108, Nr. 15. s. 1815-21.

Bibtex

@article{c0809f40118d11df803f000ea68e967b,
title = "Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans",
abstract = "BACKGROUND: Inflammatory mechanisms could be involved in the pathogenesis of both insulin resistance and atherosclerosis. Therefore, we aimed at examining whether the proinflammatory cytokine tumor necrosis factor (TNF)-alpha inhibits insulin-stimulated glucose uptake and insulin-stimulated endothelial function in humans. METHODS AND RESULTS: Healthy, lean male volunteers were studied. On each study day, 3 acetylcholine (ACh) or sodium nitroprusside (SNP) dose-response studies were performed by infusion into the brachial artery. Before and during the last 2 dose-response studies, insulin and/or TNF-alpha were coinfused. During infusion of insulin alone for 20 minutes, forearm glucose uptake increased by 220+/-44%. This increase was completely inhibited during coinfusion of TNF-alpha (started 10 min before insulin) with a more pronounced inhibition of glucose extraction than of blood flow. Furthermore, TNF-alpha inhibited the ACh forearm blood flow response (P<0.001), and this inhibition was larger during insulin infusion (P=0.01) but not further increased by NG-monomethyl-L-arginine acetate (P=0.2). Insulin potentiated the SNP response less than the ACh response and the effect of TNF-alpha was smaller (P<0.001); TNF-alpha had no effect on the SNP response without insulin infusion. Thus, TNF-alpha inhibition of the combined response to insulin and ACh was likely mediated through inhibition of NO production. CONCLUSIONS: These results support the concept that TNF-alpha could play a role in the development of insulin resistance in humans, both in muscle and in vascular tissue.",
author = "Christian Rask-Madsen and Helena Dom{\'i}nguez and Nikolaj Ihlemann and Thomas Hermann and Lars K{\o}ber and Christian Torp-Pedersen",
note = "Keywords: Acetylcholine; Adult; Arteriosclerosis; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Forearm; Glucose; Humans; Inflammation; Infusions, Intra-Arterial; Insulin; Insulin Antagonists; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Tumor Necrosis Factor-alpha; Vasodilation; omega-N-Methylarginine",
year = "2003",
doi = "10.1161/01.CIR.0000091406.72832.11",
language = "English",
volume = "108",
pages = "1815--21",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams & Wilkins",
number = "15",

}

RIS

TY - JOUR

T1 - Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans

AU - Rask-Madsen, Christian

AU - Domínguez, Helena

AU - Ihlemann, Nikolaj

AU - Hermann, Thomas

AU - Køber, Lars

AU - Torp-Pedersen, Christian

N1 - Keywords: Acetylcholine; Adult; Arteriosclerosis; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Forearm; Glucose; Humans; Inflammation; Infusions, Intra-Arterial; Insulin; Insulin Antagonists; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; Tumor Necrosis Factor-alpha; Vasodilation; omega-N-Methylarginine

PY - 2003

Y1 - 2003

N2 - BACKGROUND: Inflammatory mechanisms could be involved in the pathogenesis of both insulin resistance and atherosclerosis. Therefore, we aimed at examining whether the proinflammatory cytokine tumor necrosis factor (TNF)-alpha inhibits insulin-stimulated glucose uptake and insulin-stimulated endothelial function in humans. METHODS AND RESULTS: Healthy, lean male volunteers were studied. On each study day, 3 acetylcholine (ACh) or sodium nitroprusside (SNP) dose-response studies were performed by infusion into the brachial artery. Before and during the last 2 dose-response studies, insulin and/or TNF-alpha were coinfused. During infusion of insulin alone for 20 minutes, forearm glucose uptake increased by 220+/-44%. This increase was completely inhibited during coinfusion of TNF-alpha (started 10 min before insulin) with a more pronounced inhibition of glucose extraction than of blood flow. Furthermore, TNF-alpha inhibited the ACh forearm blood flow response (P<0.001), and this inhibition was larger during insulin infusion (P=0.01) but not further increased by NG-monomethyl-L-arginine acetate (P=0.2). Insulin potentiated the SNP response less than the ACh response and the effect of TNF-alpha was smaller (P<0.001); TNF-alpha had no effect on the SNP response without insulin infusion. Thus, TNF-alpha inhibition of the combined response to insulin and ACh was likely mediated through inhibition of NO production. CONCLUSIONS: These results support the concept that TNF-alpha could play a role in the development of insulin resistance in humans, both in muscle and in vascular tissue.

AB - BACKGROUND: Inflammatory mechanisms could be involved in the pathogenesis of both insulin resistance and atherosclerosis. Therefore, we aimed at examining whether the proinflammatory cytokine tumor necrosis factor (TNF)-alpha inhibits insulin-stimulated glucose uptake and insulin-stimulated endothelial function in humans. METHODS AND RESULTS: Healthy, lean male volunteers were studied. On each study day, 3 acetylcholine (ACh) or sodium nitroprusside (SNP) dose-response studies were performed by infusion into the brachial artery. Before and during the last 2 dose-response studies, insulin and/or TNF-alpha were coinfused. During infusion of insulin alone for 20 minutes, forearm glucose uptake increased by 220+/-44%. This increase was completely inhibited during coinfusion of TNF-alpha (started 10 min before insulin) with a more pronounced inhibition of glucose extraction than of blood flow. Furthermore, TNF-alpha inhibited the ACh forearm blood flow response (P<0.001), and this inhibition was larger during insulin infusion (P=0.01) but not further increased by NG-monomethyl-L-arginine acetate (P=0.2). Insulin potentiated the SNP response less than the ACh response and the effect of TNF-alpha was smaller (P<0.001); TNF-alpha had no effect on the SNP response without insulin infusion. Thus, TNF-alpha inhibition of the combined response to insulin and ACh was likely mediated through inhibition of NO production. CONCLUSIONS: These results support the concept that TNF-alpha could play a role in the development of insulin resistance in humans, both in muscle and in vascular tissue.

U2 - 10.1161/01.CIR.0000091406.72832.11

DO - 10.1161/01.CIR.0000091406.72832.11

M3 - Journal article

C2 - 14530204

VL - 108

SP - 1815

EP - 1821

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 15

ER -

ID: 17397379